VitalBulk Supplements

Our assessment

Based on FDA adverse event data, the overall safety profile for this brand with 6 products shows a manageable risk level, but specific serious side effects require attention. The most important finding is that the data includes reports of severe adverse events, including fatalities, which must be weighed against any therapeutic benefit. This analysis prioritizes patient safety by presenting all documented risks transparently.

Safety profile

FDA received a total of 2,150 adverse event reports for this brand across its 6 products. The most frequently reported side effects include nausea (342 reports), headache (289 reports), and dizziness (178 reports). More serious side effects include myocardial infarction (45 reports), cerebrovascular accident (22 reports), and pulmonary embolism (15 reports). Fatal outcomes were reported in 12 cases FDA FAERS ↗.

How it works

Data not available regarding the specific mechanism of action for this brand's products. The pharmacovigilance analysis focuses on the safety data provided, which does not include details on how the products interact with the body.

Our recommendation

Given the FDA data showing serious cardiovascular and cerebrovascular adverse events, patients should exercise caution. Individuals with a history of heart disease, stroke, or blood clotting disorders should consult their healthcare provider before use. Patients should monitor for chest pain, sudden shortness of breath, leg swelling, or signs of stroke (sudden weakness, difficulty speaking) and seek immediate medical attention if these occur. No specific drug interactions or dose thresholds are available in the provided data FDA FAERS ↗.